| __timestamp | Johnson & Johnson | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 22746000000 | 3243000 |
| Thursday, January 1, 2015 | 21536000000 | 2472000 |
| Friday, January 1, 2016 | 21685000000 | 2548000 |
| Sunday, January 1, 2017 | 25354000000 | 19623000 |
| Monday, January 1, 2018 | 27091000000 | 30421000 |
| Tuesday, January 1, 2019 | 27556000000 | 32793999 |
| Wednesday, January 1, 2020 | 28427000000 | 28304000 |
| Friday, January 1, 2021 | 23402000000 | 620000 |
| Saturday, January 1, 2022 | 24596000000 | 755000 |
| Sunday, January 1, 2023 | 26553000000 | 1322000 |
| Monday, January 1, 2024 | 27471000000 |
Unveiling the hidden dimensions of data
In the ever-evolving landscape of the pharmaceutical industry, understanding cost dynamics is crucial. Johnson & Johnson, a stalwart in the sector, has consistently maintained a robust cost of revenue, averaging around $25 billion annually from 2014 to 2023. This reflects their expansive operations and market dominance. In stark contrast, Viridian Therapeutics, Inc., a smaller player, has seen its cost of revenue fluctuate significantly, peaking at $32 million in 2019 before dropping to a mere $1.3 million in 2023. This dramatic 96% reduction highlights the volatility and challenges faced by emerging biotech firms. The data underscores the disparity in scale and financial strategy between established giants and burgeoning innovators. As the industry continues to evolve, these trends offer a glimpse into the strategic maneuvers companies must adopt to thrive.
Cost of Revenue Comparison: Johnson & Johnson vs Regeneron Pharmaceuticals, Inc.
Cost Insights: Breaking Down Johnson & Johnson and Cytokinetics, Incorporated's Expenses
Johnson & Johnson vs Agios Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Merck & Co., Inc. and Viridian Therapeutics, Inc.'s Expenses
Analyzing Cost of Revenue: Pfizer Inc. and Viridian Therapeutics, Inc.
Amgen Inc. vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Walgreens Boots Alliance, Inc. vs Viridian Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Grifols, S.A. vs Viridian Therapeutics, Inc.
Cost of Revenue: Key Insights for Ionis Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.
Cost Insights: Breaking Down Supernus Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.'s Expenses
Analyzing Cost of Revenue: Celldex Therapeutics, Inc. and Viridian Therapeutics, Inc.
Analyzing Cost of Revenue: Evotec SE and Viridian Therapeutics, Inc.